Tyrosinase/GP100/MART-1 peptide vaccine emulsified with Montanide ISA 51

peptide cancer vaccine targeting tyrosinase, GP100, and MART-1 · University of Southern California

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tyrosinase/GP100/MART-1 peptide vaccine emulsified with Montanide ISA 51, covering 2014-05-21 to 2014-05-21. Get the full timeline:

Most recent: Clinical Trial Update: Continuation Booster Trial After a Vaccine Combining Tyrosinase/GP100/MART-1 Peptides Emulsified With Montanide ISA 51 With or Without GM-CSF for Patients With Melanoma [Phase 2]

See pricing